Status:
COMPLETED
A Multi-center Post-Market Surveillance Registry
Lead Sponsor:
Cordis US Corp.
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
This multicenter, prospective, observational registry will evaluate the safety and performance of the CYPHER SELECT™ Sirolimus-eluting Coronary Stent, and of all future generation of commercially appr...
Detailed Description
The data will be collected in consecutive subjects treated with commercially available product and following standard clinical practice. This registry will be limited to subjects who have received onl...
Eligibility Criteria
Inclusion
- This registry will be limited to subjects who have received only the CYPHER SELECT™ Sirolimus-eluting Coronary Stent during the index procedure;
- Males and females;
Exclusion
- None.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
15000 Patients enrolled
Trial Details
Trial ID
NCT00438919
Start Date
May 1 2006
End Date
December 1 2009
Last Update
December 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique La Tour
Meyrin, Switzerland, 1217